UNCY

Unicycive Therapeutics, Inc. · NASDAQ

Sector Health Technology
Industry Biotechnology
Website unicycive.com
Employees(FY) 12
ISIN US90466Y1038

Performance

-3.7%

1W

-7.14%

1M

-24.09%

3M

+102.65%

6M

+19.86%

YTD

-25.71%

1Y

Profile

Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis; and UNI 494, which is in Phase 1 clinical trials for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.

Advanced Technical Analysis

Technical Analysis of UNCY 2024-05-10

Overview:

In analyzing the technical indicators for UNCY over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

Moving Averages (MA): The 5-day MA has been hovering around the closing prices, indic...

See more ...

Recent News & Updates

2024-05-14 19:03
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting(Globenewswire)
2024-05-13 10:53
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q1 2024(Investorplace)
2024-05-13 04:16
Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update(Globenewswire)
2024-04-30 19:00
3 Top Penny Stocks to Buy for Explosive Returns: April Edition(Yahoo Finance)
2024-04-29 01:37
These 2 Strong Buy Penny Stocks Could Rally to $9, Says Piper Sandler(Yahoo Finance)
2024-04-09 19:03
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference(Globenewswire)
2024-03-28 10:53
UNCY Stock Earnings: Unicycive Therapeutics Misses EPS for Q4 2023(Investorplace)
2024-03-28 04:15
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update(Globenewswire)
2024-03-24 19:03
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress(Globenewswire)
2024-03-13 19:03
Unicycive Announces $50 Million Private Placement(Globenewswire)
2024-03-12 19:03
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference(Globenewswire)
2024-03-07 03:12
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)(Globenewswire)
2024-03-03 18:03
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients(Globenewswire)
2024-02-13 18:03
Unicycive Therapeutics to Present Two Posters on Oxylanthanum Carbonate (OLC) at the Upcoming National Kidney Foundation Spring Clinical Meeting(Globenewswire)
2024-01-28 18:03
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference(Globenewswire)
2024-01-23 20:39
Unicycive (UNCY) Up on Positive Hyperphosphatemia Study Update(Yahoo Finance)
2024-01-22 18:03
Unicycive Therapeutics Issues Shareholder Letter to Highlight Corporate Progress and Key Upcoming Milestones(Globenewswire)
2023-12-17 18:03
Unicycive Therapeutics Announces Enrollment of First Patient in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) in Patients with Chronic Kidney Disease on Dialysis(Globenewswire)
2023-11-28 18:03
Unicycive Therapeutics to Participate in Two Investor Conferences in December 2023(Globenewswire)
2023-11-14 03:15
Unicycive Announces Third Quarter 2023 Financial Results and Provides Business Update(Globenewswire)
2023-10-22 19:03
Unicycive Therapeutics Reaches Alignment with the FDA on Path to File New Drug Application for Oxylanthanum Carbonate (OLC)(Globenewswire)
2023-09-05 19:03
Unicycive Therapeutics Strengthens Board of Directors with Appointment of Sara Kenkare-Mitra, PhD(Yahoo Finance)
2023-08-28 19:03
Unicycive Therapeutics Featured on Nasdaq Amplify Issuer Spotlight Series(Yahoo Finance)
2023-08-14 05:36
Unicycive Announces Second Quarter 2023 Financial Results and Provides Business Update(Yahoo Finance)
2023-07-21 04:30
CORRECTION FROM SOURCE: 60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)(Yahoo Finance)
2023-07-20 21:00
60 Degrees Pharmaceuticals and Unicycive Therapeutics Interviews to Air on Bloomberg TV on the RedChip Money Report(R)(Yahoo Finance)
2023-07-19 19:03
Unicycive Therapeutics to Participate in the H.C. Wainwright 2nd Annual Kidney Conference(Yahoo Finance)
2023-07-17 19:03
Unicycive Therapeutics Announces Publication of Positive Comparison of Oxylanthanum Carbonate to Commercially Available Phosphate Binders in the American Journal of Nephrology(Yahoo Finance)
2023-06-29 05:04
Unicycive Therapeutics Provides Regulatory Update on Lanthanum Dioxycarbonate Program(Yahoo Finance)
2023-06-15 19:38
Unicycive to Participate in the Healthcare Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on Tuesday, June 20th to Thursday, June 22nd at 9:00 A.M. ET(Yahoo Finance)

Page 1 of 3

previousnext